HAC3 Point-of-Care Test
.png)
HAC3 Point-of-Care Test for the Detection of Vitamin B1 Deficiency
Beriberi Detection through Salivary Testing offers Rapid Risk Identification for Malnourished Detainees - an innovative approach that aims to enhance early intervention and monitoring in challenging remote areas. - Beriberi is a debilitating disease caused by thiamine (Vitamin B1) deficiency that disproportionately affects and has a rapid onset among malnourished detainees. Surveying for thiamine deficiency among detainees in remote areas would improve the efficacy of malnutrition monitoring. Unfortunately, the collection of whole blood, stool and urine samples is impracticable in these areas, making assays based on saliva a highly valuable option. A new test strategy based on immuno-metabolic biomarkers from saliva has been proposed by EPFL for the pre-emptive detection of beriberi. Based on this, the team proposes to develop a salivary point-of-care test to identify detainees at risk of developing beriberi.
Credits Main Image: ICRC/Carol Lumingu /26.04.2016
Dr. EmelineDarçot is a project manager at the EssentialTech Centre in Lausanne, Switzerland, which harnesses innovation in support of sustainable development,humanitarian action and peace promotion. She is currently coordinating the Engineering Humanitarian Action programme within the Humanitarian Division.
She holds a PhD in Life Science from the University of Lausanne (Switzerland). After a PhD and a postdoctoral position in biomedical imaging at the University Hospital of Lausanne (CHUV), Emeline joined the EPFL EssentialTech Centre in 2021 as a project coordinator on the Ren’All Care project. She then joined the EPFL Research Office in 2022 as project manager and coordinates since then the Engineering Humanitarian Action programme within the Humanitarian Division of the EssentialTech Centre.
Integrated Settlement Planning